Skip to content

Investigation the therapeutic effect of Holy Quran voices on anxiety in cardiac care unit patients

Investigation the therapeutic effect of Holy Quran voices on anxiety in cardiac care unit patients in Hazrat Zahra hospital at Khomein city.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240609062052N2
Enrollment
68
Registered
2024-06-27
Start date
2024-06-26
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Angina pectoris. Condition 2: Essential (primary) hypertension. Condition 3: Atherosclerosis. Condition 4: myocardial infarction. Condition 5: Aortic aneurysm and dissection. Angina pectoris Essential (primary) hypertension Atherosclerosis ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Aortic aneurysm and dissection

Interventions

Intervention 1: Intervention group: the sound of the Quran in this study, which is a clinical trial type
68 patients admitted to the CCU department of Imam Khomeini Hospital (RA) in Khomein city who meet the inclusion criteria
34 people are randomly assigned to the Qur'an group. The data collection tool is a two-part questionnaire, the first part of which is related to demographic information and the second part is related
Then, for 15 minutes, they listen to Surah Hamad and verses 1 to 20 of Surah Yusuf in the voice of Professor Abdul Basit. The selection of this surah is based on the previous studies conducted in the
68 patients admitted to the CCU department of Imam Khomeini Hospital (RA) in Khomein city, who meet the criteria for entering the study
34 people are randomly assigned to the control group. The data collection tool is a two-part questionnaire, the first part of which is related to demographic information and the second part is related
Then no intervention is done for the control group and they complete the Spielberger test again like the intervention group. Then the results of control and intervention groups will be compare

Sponsors

Khomein Faculty of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having informed consent Being aware of time, place and people Having a healthy sense of hearing

Exclusion criteria

Exclusion criteria: History of drug and alcohol addiction History of mental illnesses History of new crisis such as death of first degree relatives, divorce of self or parents in the last 6 months The patient's refusal to continue participating in the study Critical condition of the patient

Design outcomes

Primary

MeasureTime frame
Anxiety score in Spielberger questionnaire. Timepoint: Before and after the intervention. Method of measurement: Anxiety:Spielberger questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPouya Zeidy

Khomein Faculty of Medical Sciences

zeidypouya@gmail.com+98 86 4622 3435

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026